Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Shares Issued: 2022-2024

Historic Shares Issued for Prime Medicine (PRME) over the last 3 years, with Dec 2024 value amounting to $38.1 million.

  • Prime Medicine's Shares Issued fell 98.07% to $373,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $38.5 million, marking a year-over-year increase of 0.47%. This contributed to the annual value of $38.1 million for FY2024, which is 5713.89% up from last year.
  • Latest data reveals that Prime Medicine reported Shares Issued of $38.1 million as of FY2024, which was up 5,713.89% from $655,000 recorded in FY2023.
  • In the past 5 years, Prime Medicine's Shares Issued ranged from a high of $185.3 million in FY2022 and a low of $655,000 during FY2023.
  • For the 3-year period, Prime Medicine's Shares Issued averaged around $74.7 million, with its median value being $38.1 million (2024).
  • Its Shares Issued has fluctuated over the past 5 years, first slumped by 99.65% in 2023, then soared by 5,713.89% in 2024.
  • Prime Medicine's Shares Issued (Yearly) stood at $185.3 million in 2022, then plummeted by 99.65% to $655,000 in 2023, then soared by 5,713.89% to $38.1 million in 2024.